tykhr
sign in
free sign up
Orphazyme A S
Biotechnology
Healthcare
ORPH
34.95M shares
NASDAQ US
traded
24 Feb 2022
listed
yes
open
1.30
52 week high
21.00
high
1.47
52 week low
1.41
low
1.26
growth
-88.81%
previous Close
2.02
P/E ratio
-2
market cap
145M
div yield
0
usd
Mar 2020
qoq
revenue
net incoming
eps
-0.74
-2.03 %
eps surprise
0.00 %
net profit margin
operating incoming
net change in cash
243M
cash on hand
cost of revenue
top